C3′/C4′-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity
C3′/C4′-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity
复制标题
DOI:
10.1002/cmdc.201200465
复制
发表时间:
2013-01-01
期刊:
影响因子:
3.4
通讯作者:
O'Doherty, George A.
中科院分区:
文献类型:
--
作者:
Hinds, John W.;McKenna, Sean B.;O'Doherty, George A.
Digitoxin, a potent cardiotonic agent that has been used continuously over centuries for the treatment of congestive heart failure, has more recently been recognized for its potential application in oncology.[1–3] The mechanism of action for digitoxin cardiotonic effect occurs via an increase of Ca2+ influx as a result of inhibition of the extracellular Na+/K+-ATPase pump.[4] In contrast to the cardiotonic effects, less detail is known for the mechanism of antitumor activity.[5] It has been shown that cell death occurs via apoptosis. Several studies led by Xie [6–8] have suggested that, in cancer cells, a cardiac glycoside-bound Na+/K+-ATPase complex signals via Src-tyrosine kinase and 1, 4, 5-triphosphoinositol (IP3), several downstream events that ultimately lead to apoptosis. This signaling pathway is believed to occur through specific isoforms of the Na+/K+-ATPase pump, which are associated with cancer and not heart tissue.These promising findings of potent cytotoxicity against cancer cells inspired many structural–activity relationship (SAR) studies, primarily aimed at understanding the role that the carbohydrate plays in the cytotoxicity of the cardiac glycosides. These studies include direct comparison of glycosidic linkage,[9, 10] the study of sugar-chain length,[10, 11] the stereochemical survey of digitoxin monosaccharides,[12] and the study of C5’-alkyl steric effect.[13] These carbohydrate-based SAR studies have led to the discovery of new sugar motifs that significantly improved the cytotoxicity across a range of cancer cell lines.[12] To date, we have found that digitoxin α-L-rhamno-monosaccharide 1 to be the most active analogue across the widest range of cell lines, with α-L-amiceto 4 having the next best results. This surprising similarity in anticancer activity of the C2’/C3’-dideoxy-rhamno-analogue (α-L-amiceto 4) motivated us to explore other deoxygenation patterns that could further enhance the cytotoxicity.